THE PHARMACOLOGY OF PARKINSONS-DISEASE - L-DOPA AND BEYOND

被引：7
|
作者：
RIEDERER, P
REYNOLDS, GP
JELLINGER, K
机构：
[1] MED SCH CAMBRIDGE,MRC,NEUROCHEM PHARMACOL UNIT,CAMBRIDGE CB2 2QH,ENGLAND
[2] MED SCH CAMBRIDGE,MRC,BRAIN TISSUE BANK,CAMBRIDGE CB2 2QH,ENGLAND
来源：
TRENDS IN PHARMACOLOGICAL SCIENCES | 1984年 / 5卷 / 01期
关键词：
D O I：
10.1016/0165-6147(84)90355-9
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：25 / 27
页数：3
相关论文
共 50 条
  • [1] L-DOPA TREATMENT AND PARKINSONS-DISEASE
    LEES, AJ
    QUARTERLY JOURNAL OF MEDICINE, 1986, 59 (230): : 535 - 547
  • [2] L-DOPA ACTION IN PARKINSONS-DISEASE
    MARSDEN, CD
    JENNER, P
    TRENDS IN NEUROSCIENCES, 1981, 4 (06) : 148 - 150
  • [3] L-DOPA AND OCULOMOTORICITY IN PARKINSONS-DISEASE
    RASCOL, O
    CLANET, M
    FRAYSSE, B
    SOULIER, MJ
    SIMONETTA, M
    DESCOUENS, D
    MONTASTRUC, JL
    ARCHIVES INTERNATIONALES DE PHYSIOLOGIE DE BIOCHIMIE ET DE BIOPHYSIQUE, 1988, 96 (03): : A127 - A127
  • [4] THE BEREITSCHAFTSPOTENTIAL, L-DOPA AND PARKINSONS-DISEASE
    DICK, JPR
    CANTELLO, R
    BURUMA, O
    GIOUX, M
    BENECKE, R
    DAY, BL
    ROTHWELL, JC
    THOMPSON, PD
    MARSDEN, CD
    ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1987, 66 (03): : 263 - 274
  • [5] THE L-DOPA TEST IN PARKINSONS-DISEASE
    ESTEGUY, M
    BONNET, AM
    KEFALOS, J
    LHERMITTE, F
    AGID, Y
    REVUE NEUROLOGIQUE, 1985, 141 (05) : 413 - 415
  • [6] L-DOPA IN PARKINSONS-DISEASE - REPLY
    BRANNAN, TS
    MARTINEZ, J
    YAHR, MD
    NEUROLOGY, 1991, 41 (10) : 1709 - 1709
  • [7] DEMENTIA AND TREATMENT WITH L-DOPA IN PARKINSONS-DISEASE
    HIETANEN, M
    TERAVAINEN, H
    MOVEMENT DISORDERS, 1988, 3 (03) : 263 - 270
  • [8] MAO AND L-DOPA TREATMENT OF PARKINSONS-DISEASE
    TYCE, GM
    DOUSA, MK
    MUENTER, MD
    JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1990, : 233 - 239
  • [9] L-DOPA ACTION IN PARKINSONS-DISEASE - REPLY
    HEFTI, F
    MELAMED, E
    TRENDS IN NEUROSCIENCES, 1981, 4 (06) : 150 - 150
  • [10] DILEMMA IN THE TREATMENT OF PARKINSONS-DISEASE WITH L-DOPA
    KUNO, S
    EUROPEAN NEUROLOGY, 1994, 34 : 17 - 19
12345